United States Zika Virus Vaccine Market Report 2017

January 2017 | 114 pages | ID: UC2FE625FC6EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Zika Virus Vaccine

Revenue, means the sales value of Zika Virus Vaccine

This report studies sales (consumption) of Zika Virus Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• NHI
• Sanofi
• GSK
• Bharat.
• Takeda
• Inovio Pharmaceuticals
• GeneOne Life Science Inc
• PaxVax
• Gilead Sciences Inc.
• Intrexon Corp.
• NewLink Genetics Corp.

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• DNA Vaccine
• Inactivated Vaccine
• Purified Inactivated Vaccine

Contents

Split by applications, this report focuses on sales, market share and growth rate of Zika Virus Vaccine in each application, can be divided into
Application
Application
Table of Contents
United States Zika Virus Vaccine Market Report 2017

1 ZIKA VIRUS VACCINE OVERVIEW

1.1 Product Overview and Scope of Zika Virus Vaccine
1.2 Classification of Zika Virus Vaccine
  1.2.1 DNA Vaccine
  1.2.2 Inactivated Vaccine
  1.2.3 Purified Inactivated Vaccine
  1.2.4 Table of Contents
1.3 Application of Zika Virus Vaccine
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Zika Virus Vaccine (2011-2021)
  1.4.1 United States Zika Virus Vaccine Sales and Growth Rate (2011-2021)
  1.4.2 United States Zika Virus Vaccine Revenue and Growth Rate (2011-2021)

2 UNITED STATES ZIKA VIRUS VACCINE COMPETITION BY MANUFACTURERS

2.1 United States Zika Virus Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Zika Virus Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Zika Virus Vaccine Average Price by Manufactures (2015 and 2016)
2.4 Zika Virus Vaccine Market Competitive Situation and Trends
  2.4.1 Zika Virus Vaccine Market Concentration Rate
  2.4.2 Zika Virus Vaccine Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ZIKA VIRUS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Zika Virus Vaccine Sales and Market Share by States (2011-2016)
3.2 United States Zika Virus Vaccine Revenue and Market Share by States (2011-2016)
3.3 United States Zika Virus Vaccine Price by States (2011-2016)

4 UNITED STATES ZIKA VIRUS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Zika Virus Vaccine Sales and Market Share by Type (2011-2016)
4.2 United States Zika Virus Vaccine Revenue and Market Share by Type (2011-2016)
4.3 United States Zika Virus Vaccine Price by Type (2011-2016)
4.4 United States Zika Virus Vaccine Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ZIKA VIRUS VACCINE SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Zika Virus Vaccine Sales and Market Share by Application (2011-2016)
5.2 United States Zika Virus Vaccine Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ZIKA VIRUS VACCINE MANUFACTURERS PROFILES/ANALYSIS

6.1 NHI
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Zika Virus Vaccine Product Type, Application and Specification
    6.1.2.1 DNA Vaccine
    6.1.2.2 Inactivated Vaccine
  6.1.3 NHI Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Zika Virus Vaccine Product Type, Application and Specification
    6.2.2.1 DNA Vaccine
    6.2.2.2 Inactivated Vaccine
  6.2.3 Sanofi Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.2 Zika Virus Vaccine Product Type, Application and Specification
    6.3.2.1 DNA Vaccine
    6.3.2.2 Inactivated Vaccine
  6.3.3 GSK Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Bharat.
  6.4.2 Zika Virus Vaccine Product Type, Application and Specification
    6.4.2.1 DNA Vaccine
    6.4.2.2 Inactivated Vaccine
  6.4.3 Bharat. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Takeda
  6.5.2 Zika Virus Vaccine Product Type, Application and Specification
    6.5.2.1 DNA Vaccine
    6.5.2.2 Inactivated Vaccine
  6.5.3 Takeda Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Inovio Pharmaceuticals
  6.6.2 Zika Virus Vaccine Product Type, Application and Specification
    6.6.2.1 DNA Vaccine
    6.6.2.2 Inactivated Vaccine
  6.6.3 Inovio Pharmaceuticals Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 GeneOne Life Science Inc
  6.7.2 Zika Virus Vaccine Product Type, Application and Specification
    6.7.2.1 DNA Vaccine
    6.7.2.2 Inactivated Vaccine
  6.7.3 GeneOne Life Science Inc Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 PaxVax
  6.8.2 Zika Virus Vaccine Product Type, Application and Specification
    6.8.2.1 DNA Vaccine
    6.8.2.2 Inactivated Vaccine
  6.8.3 PaxVax Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Gilead Sciences Inc.
  6.9.2 Zika Virus Vaccine Product Type, Application and Specification
    6.9.2.1 DNA Vaccine
    6.9.2.2 Inactivated Vaccine
  6.9.3 Gilead Sciences Inc. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Intrexon Corp.
  6.10.2 Zika Virus Vaccine Product Type, Application and Specification
    6.10.2.1 DNA Vaccine
    6.10.2.2 Inactivated Vaccine
  6.10.3 Intrexon Corp. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 NewLink Genetics Corp.

7 ZIKA VIRUS VACCINE MANUFACTURING COST ANALYSIS

7.1 Zika Virus Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Zika Virus Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Zika Virus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Zika Virus Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ZIKA VIRUS VACCINE MARKET FORECAST (2016-2021)

11.1 United States Zika Virus Vaccine Sales, Revenue Forecast (2016-2021)
11.2 United States Zika Virus Vaccine Sales Forecast by Type (2016-2021)
11.3 United States Zika Virus Vaccine Sales Forecast by Application (2016-2021)
11.4 Zika Virus Vaccine Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Zika Virus Vaccine
Table Classification of Zika Virus Vaccine
Figure United States Sales Market Share of Zika Virus Vaccine by Type in 2015
Figure DNA Vaccine Picture
Figure Inactivated Vaccine Picture
Figure Purified Inactivated Vaccine Picture
Figure Table of Contents Picture
Table Application of Zika Virus Vaccine
Figure United States Sales Market Share of Zika Virus Vaccine by Application in 2015
Figure United States Zika Virus Vaccine Sales and Growth Rate (2011-2021)
Figure United States Zika Virus Vaccine Revenue and Growth Rate (2011-2021)
Table United States Zika Virus Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Zika Virus Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Zika Virus Vaccine Sales Share by Manufacturers
Figure 2016 Zika Virus Vaccine Sales Share by Manufacturers
Table United States Zika Virus Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Zika Virus Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Zika Virus Vaccine Revenue Share by Manufacturers
Table 2016 United States Zika Virus Vaccine Revenue Share by Manufacturers
Table United States Market Zika Virus Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Zika Virus Vaccine Average Price of Key Manufacturers in 2015
Figure Zika Virus Vaccine Market Share of Top 3 Manufacturers
Figure Zika Virus Vaccine Market Share of Top 5 Manufacturers
Table United States Zika Virus Vaccine Sales by States (2011-2016)
Table United States Zika Virus Vaccine Sales Share by States (2011-2016)
Figure United States Zika Virus Vaccine Sales Market Share by States in 2015
Table United States Zika Virus Vaccine Revenue and Market Share by States (2011-2016)
Table United States Zika Virus Vaccine Revenue Share by States (2011-2016)
Figure Revenue Market Share of Zika Virus Vaccine by States (2011-2016)
Table United States Zika Virus Vaccine Price by States (2011-2016)
Table United States Zika Virus Vaccine Sales by Type (2011-2016)
Table United States Zika Virus Vaccine Sales Share by Type (2011-2016)
Figure United States Zika Virus Vaccine Sales Market Share by Type in 2015
Table United States Zika Virus Vaccine Revenue and Market Share by Type (2011-2016)
Table United States Zika Virus Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Zika Virus Vaccine by Type (2011-2016)
Table United States Zika Virus Vaccine Price by Type (2011-2016)
Figure United States Zika Virus Vaccine Sales Growth Rate by Type (2011-2016)
Table United States Zika Virus Vaccine Sales by Application (2011-2016)
Table United States Zika Virus Vaccine Sales Market Share by Application (2011-2016)
Figure United States Zika Virus Vaccine Sales Market Share by Application in 2015
Table United States Zika Virus Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States Zika Virus Vaccine Sales Growth Rate by Application (2011-2016)
Table NHI Basic Information List
Table NHI Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure NHI Zika Virus Vaccine Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Zika Virus Vaccine Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Zika Virus Vaccine Sales Market Share (2011-2016)
Table Bharat. Basic Information List
Table Bharat. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bharat. Zika Virus Vaccine Sales Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Zika Virus Vaccine Sales Market Share (2011-2016)
Table Inovio Pharmaceuticals Basic Information List
Table Inovio Pharmaceuticals Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Inovio Pharmaceuticals Zika Virus Vaccine Sales Market Share (2011-2016)
Table GeneOne Life Science Inc Basic Information List
Table GeneOne Life Science Inc Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table GeneOne Life Science Inc Zika Virus Vaccine Sales Market Share (2011-2016)
Table PaxVax Basic Information List
Table PaxVax Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table PaxVax Zika Virus Vaccine Sales Market Share (2011-2016)
Table Gilead Sciences Inc. Basic Information List
Table Gilead Sciences Inc. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead Sciences Inc. Zika Virus Vaccine Sales Market Share (2011-2016)
Table Intrexon Corp. Basic Information List
Table Intrexon Corp. Zika Virus Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intrexon Corp. Zika Virus Vaccine Sales Market Share (2011-2016)
Table NewLink Genetics Corp. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Zika Virus Vaccine
Figure Manufacturing Process Analysis of Zika Virus Vaccine
Figure Zika Virus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Zika Virus Vaccine Major Manufacturers in 2015
Table Major Buyers of Zika Virus Vaccine
Table Distributors/Traders List
Figure United States Zika Virus Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States Zika Virus Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States Zika Virus Vaccine Production Forecast by Type (2016-2021)
Table United States Zika Virus Vaccine Consumption Forecast by Application (2016-2021)
Table United States Zika Virus Vaccine Sales Forecast by States (2016-2021)
Table United States Zika Virus Vaccine Sales Share Forecast by States (2016-2021)